Molecule Details
| InChIKey | CRDNMYFJWFXOCH-BUHFOSPRSA-N |
|---|---|
| Canonical SMILES | O=C1Nc2ccccc2/C1=C1\Nc2ccccc2C1=O |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | N/A |
| Source | TTD_MultiTarget |
2D Structure
DrugBank Annotations
| DrugBank ID | DB12379 |
|---|---|
| Drug Name | Indirubin |
| CAS Number | 479-41-4 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment). |
Categories: Antibiotics, Antineoplastic Antineoplastic Agents Coloring Agents Compounds used in a research, industrial, or household setting Cytochrome P-450 CYP1A1 Substrates Cytochrome P-450 Substrates Heterocyclic Compounds, Fused-Ring Leukemia, Myelogenous, Chronic, BCR-ABL Positive Protein Kinase Inhibitors
Cross-references: BindingDB: 50349806 ChemSpider: 4514277 PubChem:5359405 PubChem:347828627 Wikipedia: Indirubin ZINC: ZINC000100015416